HealthDay - THURSDAY, Aug. 21 (HealthDay News) -- U.S. drug regulators saidThursday that they were investigating whether the cholesterol-loweringdrug Vytorin might be linked to cancer.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.